Journal Article

Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning

Guo, Zheng, Zheng, Weicheng, Cai, Hao, Song, Kai, Yan, Haidan, Wang, Xianlong, He, Jun, Guan, Qingzhou, Li, Xiangyu, Liu, Huaping, Chen, Rou

2017

Overview

Background The Connectivity Map (CMAP) database, an important public data source for drug repositioning, archives gene expression profiles from cancer cell lines treated with and without bioactive small molecules. However, there are only one or two technical replicates for each cell line under one treatment condition. For such small-scale data, current fold-changes-based methods lack statistical control in identifying differentially expressed genes (DEGs) in treated cells. Especially, one-to-one comparison may result in too many drug-irrelevant DEGs due to random experimental factors. To tackle this problem, CMAP adopts a pattern-matching strategy to build “connection” between disease signatures and gene expression changes associated with drug treatments. However, many drug-irrelevant genes may blur the “connection” if all the genes are used instead of pre-selected DEGs induced by drug treatments. Methods We applied OneComp, a customized version of RankComp, to identify DEGs in such small-scale cell line datasets. For a cell line, a list of gene pairs with stable relative expression orderings (REOs) were identified in a large collection of control cell samples measured in different experiments and they formed the background stable REOs. When applying OneComp to a small-scale cell line dataset, the background stable REOs were customized by filtering out the gene pairs with reversal REOs in the control samples of the analyzed dataset. Results In simulated data, the consistency scores of overlapping genes between DEGs identified by OneComp and SAM were all higher than 99%, while the consistency score of the DEGs solely identified by OneComp was 96.85% according to the observed expression difference method. The usefulness of OneComp was exemplified in drug repositioning by identifying phenformin and metformin related genes using small-scale cell line datasets which helped to support them as a potential anti-tumor drug for non-small-cell lung carcinoma, while the pattern-matching strategy adopted by CMAP missed the two connections. The implementation of OneComp is available at https://github.com/pathint/reoa . Conclusions OneComp performed well in both the simulated and real data. It is useful in drug repositioning studies by helping to find hidden “connections” between drugs and diseases.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Algorithms / Analysis / Antidiabetics / Biomedical and Life Sciences / Biomedicine / Cancer therapies / Carcinoma, Non-Small-Cell Lung - genetics / Cell Line / Databases, Genetic / Datasets / Differentially expressed genes / Disease / Dosage and administration / Drug Repositioning / Drugs / Gene expression / Gene Expression Regulation, Neoplastic - drug effects / Humans / Kinases / Laboratories / Lung cancer / Lung carcinoma / Lung Neoplasms - genetics / Medical bioinformatics / Medicine/Public Health / Metabolism / Metformin / Metformin - pharmacology / Non-small cell lung carcinoma / Phenformin / Phenformin - pharmacology / Protein Interaction Maps - genetics / Sample Size / Statistics as Topic / The Connectivity Map / Transcriptome / Tumor cell lines